Stocks and Investing
Stocks and Investing
Thu, November 9, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 8, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Annabel Samimy Upgraded (SUPN) to Strong Buy on, Nov 8th, 2017
Annabel Samimy of Stifel, Upgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Strong Buy on, Nov 8th, 2017.
Annabel has made no other calls on SUPN in the last 4 months.
There are 2 other peers that have a rating on SUPN. Out of the 2 peers that are also analyzing SUPN, all agree with Annabel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Amsellem of "Piper Sandler" Downgraded from Buy to Hold on, Monday, July 17th, 2017
- Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017